ArticleScientific reports2026
Perfluoroalkyl compound levels in breast milk of mothers in Riyadh, Kingdom of Saudi Arabia.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Per- and Polyfluoroalkyl substances (PFAS) are persistent environmental contaminants widely used in consumer and industrial applications including stain- and water-repellent textiles, nonstick cookware, firefighting foams, and food packaging. Their persistence and bioaccumulation potential raise concerns about early-life exposure through breastfeeding. Despite increasing international attention, no biomonitoring data on PFAS in breast milk have been reported from Saudi Arabia. The study aim to quantify perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in breast milk from lactating women in Riyadh and estimate infant exposure via breastfeeding using standardized exposure assessment methods. Breast milk samples were collected from 25 mothers within 30 days postpartum. Samples were analyzed by LC-MS/MS following solid-phase extraction. Estimated daily intake (EDI) for PFOA and PFOS was calculated using the equation EDI = (CBM × VBM) / BW, assuming an average infant body weight of 2.5 kg and daily milk intake of 292.5 mL during early infancy. Quantifiable concentrations (> LLOQ = 25 ng/L) were detected in 4 of 25 participants. PFOA concentrations ranged from < LLOQ to 73.3 ng/L, and PFOS concentrations ranged from < LLOQ to 85.2 ng/L. Median concentrations for both compounds remained < LLOQ. Infant EDI values were below the U.S. EPA oral reference dose (20 ng/kg-bw/day) but exceeded EFSA benchmark values in 12% of samples for PFOA (EFSA = 0.857 ng/kg-bw/day) and 16% of samples for PFOS (EFSA = 1.857 ng/kg-bw/day). This study provides the first biomonitoring evidence of PFAS in breast milk in Saudi Arabia, demonstrating low but measurable exposure among lactating women. The findings underscore a need for expanded biomonitoring and assessment of potential exposure sources in the region.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.